Imra America Partners with MagArray
!%Imra America Inc.%! of Ann Arbor, Mich., and MagArray Inc. of Sunnyvale, Calif., are collaborating to develop MagArray’s magneto-nanoparticle immunoassay technology, which is based on research from Stanford University. The companies will develop highly sensitive immunoassay sensor systems. If the work progresses as planned, Imra will support MagArray’s development with funding of up to $10 million over the next 3 1/2 years. Imra also will provide scientific and technical support. MagArray’s technology eventually could play a leading role in the way that cancer and other serious diseases are diagnosed and treated.
LATEST NEWS
- CLEO Heads to the East Coast
Apr 29, 2024
- Laser-Based Gas Analyzer Developed to Detect Air Pollution
Apr 29, 2024
- Qubits Could be Stored in Flash-Like Memory
Apr 29, 2024
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024